For patients undergoing radical radiotherapy, various immune cells, namely, CD8+ T cells, neutrophils, macrophages, and dendritic cells are more enriched in cluster 2, the group with a worse prognosis, and the tumor purity is lower. The gene discussed is CD8A; the disease is neoplasm.